Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CV787 in hormone refractory metastatic prostate cancer
NCT00116155Phase 2Completed
- Sponsor
- Cell Genesys
01
Overview
A Phase 2 trial of CG7870 in prostate cancer (PCa), sponsored by Cell Genesys. Status: completed.
02
Drugs
CG7870
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00116155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116155.